Britain Investigating Positive Morphine Tests in Racehorses

  • Print
  • Email
  • Favorite
  • Share
  • Newsletters

Five horses that ran in recent race meetings and under the care of various trainers have tested positive for morphine in their 'A' samples, according to a statement from the British Horseracing Authority (BHA).

Morphine is a prohibited substance on race day but is allowed during training. The test results were reported by LGC analytical laboratory (formerly HFL Sport Science).

The BHA said it will not make public any information regarding the identity of the horses, trainers or owners, the races they competed in, or the dates on which the samples were taken until all necessary processes are completed. The BHA said the process includes counter analysis of respective 'B' samples, if requested by those connected with any of the horses, and its own investigations.

Authorities are investigating whether there could be any link between the cases and, if so, what that link might be. Due to the shared characteristics of these cases, the authority said, it is not possible to rule out further positives from post-race samples obtained in recent weeks. The BHA has been in communication with the National Trainers Federation and trainers of the horses in question on this matter.

Once all processes have been completed the cases will be put before a disciplinary panel which will decide what action, if any, should be taken. This could include disqualifying the horses in question from relevant races.

Originally published on BloodHorse.com.

About the Author

The Blood-Horse Staff

The Blood-Horse is the leading weekly publication devoted to international Thoroughbred racing and breeding. Since 1916, the staff of The Blood-Horse has served the Thoroughbred community with the highest standards of journalistic excellence to provide comprehensive and timely editorial coverage and analysis.

Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners